
Reset all filters
01 1Boehringer Ingelheim RCV GmbH & Co KG
Reset all filters
01 1Moxetumomab pasudotox-tdfk
Reset all filters
01 1Germany
NDC Package Code : 68594-029
Start Marketing Date : 2018-09-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT
We have 1 companies offering Moxetumomab Pasudotox
Get in contact with the supplier of your choice: